Guardion Health Sciences, Inc. (GHSI)
OTCMKTS
· Delayed Price · Currency is USD
3.220
-0.070 (-2.13%)
Oct 30, 2024, 3:17 PM EDT
Guardion Health Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 11.89 | 11.91 | 10.64 | 6.95 | 1.89 | 0.88 | Upgrade
|
| Other Revenue | 0.34 | 0.34 | 0.41 | 0.28 | 0 | 0.02 | Upgrade
|
| Revenue | 12.23 | 12.25 | 11.05 | 7.23 | 1.89 | 0.9 | Upgrade
|
| Revenue Growth (YoY) | 119.79% | 10.85% | 52.77% | 282.74% | 109.30% | -4.16% | Upgrade
|
| Cost of Revenue | 6.78 | 6.85 | 6.53 | 4.12 | 1.95 | 0.34 | Upgrade
|
| Gross Profit | 5.45 | 5.39 | 4.52 | 3.11 | -0.06 | 0.56 | Upgrade
|
| Selling, General & Admin | 8.88 | 9.19 | 11.65 | 13.53 | 8.9 | 9.3 | Upgrade
|
| Research & Development | 0.15 | 0.15 | 0.19 | 0.06 | 0.16 | 0.19 | Upgrade
|
| Operating Expenses | 9.02 | 9.34 | 11.84 | 13.59 | 9.06 | 9.5 | Upgrade
|
| Operating Income | -3.58 | -3.94 | -7.32 | -10.48 | -9.12 | -8.93 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | -0.26 | Upgrade
|
| Interest & Investment Income | 0.38 | 0.38 | 0.15 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.8 | 3.98 | 2.35 | 0 | -0.01 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -4.99 | 0.42 | -4.82 | -10.48 | -9.14 | -9.31 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -2.1 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -11.89 | - | -1.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.28 | -0.26 | -0.01 | -0.16 | -0.05 | - | Upgrade
|
| Asset Writedown | - | - | -10.09 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -0.11 | 0.62 | - | Upgrade
|
| Pretax Income | -5.28 | 0.16 | -14.92 | -24.75 | -8.57 | -10.88 | Upgrade
|
| Net Income | 6.37 | 0.16 | -14.92 | -24.75 | -8.57 | -10.88 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.94 | - | - | - | Upgrade
|
| Net Income to Common | 6.37 | 0.16 | -15.86 | -24.75 | -8.57 | -10.88 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 2.26% | 13.37% | 136.61% | 66.16% | 134.56% | 80.64% | Upgrade
|
| EPS (Basic) | 4.99 | 0.12 | -14.15 | -52.23 | -30.06 | -89.49 | Upgrade
|
| EPS (Diluted) | 4.99 | 0.12 | -14.15 | -52.23 | -30.06 | -89.49 | Upgrade
|
| Free Cash Flow | -3.92 | -4.37 | -7.45 | -10.72 | -8.05 | -6.2 | Upgrade
|
| Free Cash Flow Per Share | -3.07 | -3.44 | -6.65 | -22.62 | -28.25 | -51.01 | Upgrade
|
| Gross Margin | 44.56% | 44.04% | 40.91% | 43.00% | -3.00% | 62.20% | Upgrade
|
| Operating Margin | -29.24% | -32.18% | -66.26% | -144.94% | -482.49% | -989.37% | Upgrade
|
| Profit Margin | 52.13% | 1.29% | -143.57% | -342.11% | -453.56% | -1204.77% | Upgrade
|
| Free Cash Flow Margin | -32.05% | -35.71% | -67.44% | -148.19% | -426.21% | -686.77% | Upgrade
|
| EBITDA | -3.56 | -3.92 | -6.07 | -9.7 | -9.05 | -8.46 | Upgrade
|
| EBITDA Margin | -29.08% | -32.02% | -54.95% | -134.11% | - | - | Upgrade
|
| D&A For EBITDA | 0.02 | 0.02 | 1.25 | 0.78 | 0.07 | 0.48 | Upgrade
|
| EBIT | -3.58 | -3.94 | -7.32 | -10.48 | -9.12 | -8.93 | Upgrade
|
| EBIT Margin | -29.24% | -32.18% | -66.26% | -144.94% | - | - | Upgrade
|
| Revenue as Reported | 12.25 | 12.25 | 11.05 | 7.23 | 1.89 | 0.9 | Upgrade
|
| Advertising Expenses | - | 1.45 | 1.62 | 0.16 | 0.04 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.